Pfizer Licensing, Development & Alliances
Pfizer Animal Health - Business Development & Global Alliances

About Us

The Business Development & Global Alliances group within Pfizer Animal Health is a team of medical, scientific and business experts.

Our goal to identify and bring to market innovative approaches to veterinary medicine that will help pets live longer, healthier lives, enhance the health and productivity of livestock, and improve the safety and quality of the food supply.

What We Do

Outside Pfizer, we work directly with partners across a vast array of institutions who share a common vision and complementary strengths to build winning collaborations and alliances.

Within Pfizer, we work closely with colleagues in Marketing, Research & Development and other parts of the organization to provide rapid and comprehensive evaluation of external opportunities.

As a general rule, Global Alliances takes the lead in early stage, collaborative research projects. When opportunities involve in-licensing of early or late stage projects, or marked products, Business Development leads the discussion with outside parties.

How We Do It

Our partnering process has been structured to provide a rapid and comprehensive evaluation of the scientific merits, market potential and commercial viability of all opportunities.

To facilitate initial contact, subsequent communication during all phases of the review process, and support for our partners after an agreement is reached, we have established a single gateway for opportunity submission. Submit Your Animal Health Opportunity

Areas of Interest

We are actively seeking external opportunities for technologies, biologics and compounds in several therapeutic areas, especially those with unmet medical needs.

• Allergy / Antipruritics
• Antiparasitics
• Appetite Regulation / CNS
• Endocrine / Reproduction / Performance
• Immunomodulation
• Infectious Diseases - Prevention
• Infectious Diseases - Therapy
• Oncology
• Pain & Inflammation / Musculoskeletal Disease
• Technologies, including improvements in the delivery of medicines and vaccines.